Welcome to your Daily Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
RadNet Acquires CIMAR UK to Boost AI Imaging and Screening
RadNet, Inc., a US leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, announced the acquisition of CIMAR UK, a leading provider of cloud-native healthcare image management solutions. CIMAR will be integrated into DeepHealth, RadNet’s wholly owned subsidiary and a global leader in AI-powered health informatics, to advance connected imaging-based care.
enGene Reports 62% Complete Response for Detalimogene
enGene Holdings Inc. a clinical-stage, non-viral genetic medicines company, reported additional preliminary data from the pivotal cohort of its ongoing, Phase 2 LEGEND trial of detalimogene voraplasmid (also known as detalimogene and previously EG-70) in high-risk, Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) patients with carcinoma in situ (CIS) with or without concomitant papillary disease. Detalimogene’s preliminary data to date and differentiated profile continue to support the Company’s planned Biologics License Application (BLA) submission in the second half of 2026.
SOPHiA GENETICS, Element Bio Partner for AI Genomics
SOPHiA GENETICS, a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the pace and accessibility of scientific discovery, announced at the Association for Molecular Pathology (AMP) Annual Meeting a partnership that unites sequencing and AI analytics to streamline genomic workflows and accelerate the research supporting precision medicine.
Ontada Unveils Real-World Control Framework for Phase 2 Trials
Ontada, a leading provider of real-world oncology data and insights, is presenting new research at ISPOR Europe 2025 in Glasgow, Scotland. The study, titled “A Framework for Accelerating Clinical Development with Real-World External Control Arms in Phase 2 Trials,” addresses a key challenge in early-stage clinical research by offering a scalable method to interpret single-arm trial results. The research demonstrates how external control arms can strengthen Phase 2 trials, which often face limited patient numbers and slow enrollment, especially in oncology and rare diseases.
CTG and Hippocratic AI Launch Safe AI for U.S. Healthcare
CTG, which is part of Cegeka, is known for providing IT and business solutions that help healthcare organizations improve their digital abilities. They have now announced a strategic partnership with Hippocratic AI, a global leader in AI that is safe for patients and focused on healthcare. With this collaboration, CTG will offer managed AI services and consulting support to help healthcare providers use and grow Hippocratic AI’s solutions throughout the U.S. healthcare system.
To share your insights, please write to us at tony@intentamplify.com
